MedCap AB (publ) (STO:MCAP)
Sweden · Delayed Price · Currency is SEK 556.50
+7.50 (1.37%)
Jul 24, 2026, 5:29 PM CET
MedCap AB Cash Flow Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 345.5 | 302.9 | 272.3 | 227.5 | 170.9 | 127 |
Depreciation & Amortization | 176.5 | 153.3 | 115.4 | 104 | 87.8 | 75.5 |
Other Adjustments | -107.8 | -118.3 | -99.3 | -34.2 | -27 | -30.8 |
Change in Receivables | -42.4 | -47 | 44.1 | -8.3 | -159.8 | -36.5 |
Changes in Inventories | 18.6 | 22.4 | 42.3 | -47.2 | -10.8 | -16 |
Changes in Other Operating Activities | -2.8 | 29.4 | -14.7 | -13.9 | 24.4 | -2.9 |
Operating Cash Flow | 387.8 | 342.7 | 360 | 228 | 85.5 | 116.3 |
Operating Cash Flow Growth | 18.96% | -4.81% | 57.89% | 166.67% | -26.48% | 0.61% |
Capital Expenditures | -24 | -25.7 | -41.7 | -22.1 | -26.3 | -45.3 |
Purchases of Intangible Assets | -42.6 | -36.5 | -24.5 | -17.2 | -18 | -15.6 |
Cash Acquisitions | -418.2 | -330.1 | -62.7 | -113.1 | -11.9 | -4.6 |
Other Investing Activities | 1 | 1 | 0.1 | 0.1 | 0.1 | 0.7 |
Investing Cash Flow | -483.9 | -391.3 | -128.8 | -152.3 | -56.1 | -64.8 |
Short-Term Debt Issued | 0.3 | -0.7 | -15 | -36.9 | -2.8 | 0.9 |
Net Short-Term Debt Issued (Repaid) | 0.3 | -0.7 | -15 | -36.9 | -2.8 | 0.9 |
Long-Term Debt Issued | 397 | 181 | 0 | - | 120 | - |
Long-Term Debt Repaid | -342 | -132.1 | -67 | -84.6 | -54.4 | -66 |
Net Long-Term Debt Issued (Repaid) | 55 | 48.9 | -67 | -84.6 | 65.6 | -66 |
Issuance of Common Stock | 14 | 28.3 | 35.9 | - | - | 1.1 |
Repurchase of Common Stock | -25 | -26.1 | - | - | - | - |
Net Common Stock Issued (Repurchased) | -11 | 2.2 | 35.9 | - | - | 1.1 |
Other Financing Activities | -5.8 | 1.7 | - | 1.8 | -1.7 | - |
Financing Cash Flow | 38.7 | 52.2 | -46.1 | -119.7 | 61.2 | -64.1 |
Effect of Exchange Rate Changes on Cash and Cash Equivalents | 9.1 | -3.4 | -3.2 | -4.1 | 5.9 | 5.7 |
Net Cash Flow | -57.4 | 3.6 | 185.2 | -43.9 | 90.5 | -12.5 |
Free Cash Flow | 363.8 | 317 | 318.3 | 205.9 | 59.2 | 71 |
Free Cash Flow Growth | 21.96% | -0.41% | 54.59% | 247.80% | -16.62% | -31.93% |
FCF Margin | 15.69% | 14.74% | 17.15% | 12.75% | 5.13% | 7.48% |
Free Cash Flow Per Share | 24.25 | 21.13 | 21.41 | 13.86 | 4.00 | 4.80 |
Levered Free Cash Flow | 464.4 | 447.4 | 226.7 | 71.5 | 255.5 | 42.7 |
Unlevered Free Cash Flow | 433.98 | 410.71 | 319.16 | 197.34 | 207.77 | 117.77 |